NGeneBio Revenue

Medical Equipment Manufacturing • 307, Daerung Post-tower 1, Korea, Republic of • 21-50 Employees

NGeneBio revenue & valuation

Annual revenue	$1,796,655
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues	$5,800,000
Total funding	$10,600,000

Key Contacts at NGeneBio

Neha Roy

Business Director_India, South Asia And Mena Region

Myung Joon Song

Managing Director, Chief Business Officer 사업총괄

재안 손

Director Diagnostics Business Div.

Kwang Joong Kim

Chief Technology Officer

Company overview

Headquarters	307, Daerung Post-tower 1, 288, Digital-ro, Guro-gu, Seoul, 08390, KR
Phone number	+8228679798
Website	ngenebio.com
NAICS	3391
SIC	873
Keywords	Medical Device, Genetic Testing, Diagnostics, Cancer Diagnostics, Next Generation Sequencing (Ngs), Brcaaccutest, Clinical Ngs, Companion Diagnostics (Cdx), Molecular Diagnostics (Mdx), Ngs Ivd, Ngs Analysis Software, Ngeneanalysys, In Vitro Diagnostics (Ivd)
Founded	2015
Employees	21-50
Socials

NGeneBio Email Formats

NGeneBio uses 2 email formats. The most common is {last name} (e.g., doe@snu.ac.kr), used 76.9% of the time.

Format	Example	Percentage
{last name}	doe@snu.ac.kr	76.9%
{first name}	john@snu.ac.kr	23.1%

About NGeneBio

NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecurix and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to provide clinically validated NGS based IVD/CDx products/services with convergence of innovative bioinformatics and SW development capacity for global market. For more information, visit www.ngenebio.com.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Director

Employees by Department

NGeneBio has 5 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore NGeneBio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2018-12-20	5	$10,600,000

Funding Insights

$10,600,000

Total funding amount

$10,600,000

Most recent funding amount

Number of funding rounds

NGeneBio Tech Stack

Discover the technologies and tools that power NGeneBio's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

jQuery CDN

CDN

jQuery

JavaScript libraries

Open Graph

Miscellaneous

GSAP

JavaScript frameworks

Sectigo

SSL/TLS certificate authorities

Swiper

JavaScript libraries

Microsoft ASP.NET

Web frameworks

jQuery UI

JavaScript libraries

Unpkg

CDN

AOS

JavaScript libraries

cdnjs

CDN

Frequently asked questions

NGeneBio is located in 307, Daerung Post-tower 1, KR.

You can reach NGeneBio at +8228679798.

NGeneBio generates an estimated annual revenue of $1,796,655. This revenue figure reflects the company's market position and business performance in its industry.

NGeneBio has an estimated valuation of $5,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

NGeneBio was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

NGeneBio has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

NGeneBio has raised a total of $10,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at NGeneBio

Neha Roy

Business Director_India, South Asia And Mena Region

Myung Joon Song

Managing Director, Chief Business Officer 사업총괄

재안 손

Director Diagnostics Business Div.

Kwang Joong Kim

Chief Technology Officer

4.8